Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target

Abstract Diffuse large B-cell lymphoma (DLBC) is the most common subtype of non-Hodgkin lymphoma, characterized by its aggressive nature and poor prognosis in advanced stages. Despite advances in treatment, the molecular mechanisms driving DLBC progression remain incompletely understood, necessitati...

Full description

Saved in:
Bibliographic Details
Main Authors: Junaid Abid, Mahmood Basil A. Al-Rawi, Ahmad Mahmood, An Li, Tiemin Jiang
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Hereditas
Subjects:
Online Access:https://doi.org/10.1186/s41065-025-00411-w
Tags: Add Tag
No Tags, Be the first to tag this record!